These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 31724454

  • 1. MicroRNA-139-5p modulates the growth and metastasis of malignant melanoma cells via the PI3K/AKT signaling pathway by binding to IGF1R.
    Yang C, Xia Z, Zhu L, Li Y, Zheng Z, Liang J, Wu L.
    Cell Cycle; 2019 Dec; 18(24):3513-3524. PubMed ID: 31724454
    [Abstract] [Full Text] [Related]

  • 2. miR-188-5p regulates proliferation and invasion via PI3K/Akt/MMP-2/9 signaling in keloids.
    Zhu W, Wu X, Yang B, Yao X, Cui X, Xu P, Chen X.
    Acta Biochim Biophys Sin (Shanghai); 2019 Feb 01; 51(2):185-196. PubMed ID: 30668826
    [Abstract] [Full Text] [Related]

  • 3. CircRNA hsa_circ_0002577 accelerates endometrial cancer progression through activating IGF1R/PI3K/Akt pathway.
    Wang Y, Yin L, Sun X.
    J Exp Clin Cancer Res; 2020 Aug 26; 39(1):169. PubMed ID: 32847606
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-129-5p suppresses proliferation, migration and invasion of retinoblastoma cells through PI3K/AKT signaling pathway by targeting PAX6.
    Liu Y, Liang G, Wang H, Liu Z.
    Pathol Res Pract; 2019 Dec 26; 215(12):152641. PubMed ID: 31727502
    [Abstract] [Full Text] [Related]

  • 5. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
    Luo X, Dong J, He X, Shen L, Long C, Liu F, Liu X, Lin T, He D, Wei G.
    Biomed Pharmacother; 2020 May 26; 125():109880. PubMed ID: 32004974
    [Abstract] [Full Text] [Related]

  • 6. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y, Li S, Li J, Wang D, Li Q.
    Cell Physiol Biochem; 2017 May 26; 42(4):1431-1446. PubMed ID: 28715819
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-493-5p inhibits proliferation and metastasis of osteosarcoma cells by targeting Kruppel-like factor 5.
    Zhang Z, Luo G, Yu C, Yu G, Jiang R, Shi X.
    J Cell Physiol; 2019 Aug 26; 234(8):13525-13533. PubMed ID: 30773645
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-7-5p regulates the proliferation and migration of intestinal epithelial cells by targeting trefoil factor 3 via inhibiting the phosphoinositide 3-kinase/Akt signalling pathway.
    Guo J, Xu L, Teng X, Sun M.
    Int J Mol Med; 2017 Nov 26; 40(5):1435-1443. PubMed ID: 28901375
    [Abstract] [Full Text] [Related]

  • 9. Down-regulated microRNA-223 or elevated ZIC1 inhibits the development of pancreatic cancer via inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Zhu J, Lv J, Chen J, Zhang X, Ji Y.
    Cell Cycle; 2020 Nov 26; 19(21):2851-2865. PubMed ID: 33064959
    [Abstract] [Full Text] [Related]

  • 10. Declination of long noncoding RNA paternally expressed gene 10 inhibits A375 cells proliferation, migration, and invasion via mediating microRNA-33a.
    Fu Y, Bi Y, Wang F, Chen X, Liu H.
    J Cell Biochem; 2019 Dec 26; 120(12):19868-19877. PubMed ID: 31318088
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression.
    Zhou YM, Yao YL, Liu W, Shen XM, Shi LJ, Wu L.
    Cancer Biomark; 2020 Dec 26; 29(1):51-67. PubMed ID: 32568182
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-939-5p directly targets IGF-1R to inhibit the aggressive phenotypes of osteosarcoma through deactivating the PI3K/Akt pathway.
    Zhao X, Li J, Yu D.
    Int J Mol Med; 2019 Nov 26; 44(5):1833-1843. PubMed ID: 31545400
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of miR-138 in patients with malignant melanoma through targeting of PDK1 in the PI3K/AKT autophagy signaling pathway.
    Meng F, Zhang Y, Li X, Wang J, Wang Z.
    Oncol Rep; 2017 Sep 26; 38(3):1655-1662. PubMed ID: 28731179
    [Abstract] [Full Text] [Related]

  • 14. MiR-139-5p/SLC7A11 inhibits the proliferation, invasion and metastasis of pancreatic carcinoma via PI3K/Akt signaling pathway.
    Zhu JH, De Mello RA, Yan QL, Wang JW, Chen Y, Ye QH, Wang ZJ, Tang HJ, Huang T.
    Biochim Biophys Acta Mol Basis Dis; 2020 Jun 01; 1866(6):165747. PubMed ID: 32109492
    [Abstract] [Full Text] [Related]

  • 15. Transfer of miR-15a-5p by placental exosomes promotes pre-eclampsia progression by regulating PI3K/AKT signaling pathway via CDK1.
    Wang Y, Du X, Wang J.
    Mol Immunol; 2020 Dec 01; 128():277-286. PubMed ID: 33197745
    [Abstract] [Full Text] [Related]

  • 16. Effects of miR-145-5p through NRAS on the cell proliferation, apoptosis, migration, and invasion in melanoma by inhibiting MAPK and PI3K/AKT pathways.
    Liu S, Gao G, Yan D, Chen X, Yao X, Guo S, Li G, Zhao Y.
    Cancer Med; 2017 Apr 01; 6(4):819-833. PubMed ID: 28332309
    [Abstract] [Full Text] [Related]

  • 17. FoxP3-miR-150-5p/3p suppresses ovarian tumorigenesis via an IGF1R/IRS1 pathway feedback loop.
    Zhang Q, Zhou X, Wan M, Zeng X, Luo J, Xu Y, Ji L, Zhang JA, Fan P, Zhong J, Wu J.
    Cell Death Dis; 2021 Mar 15; 12(3):275. PubMed ID: 33723215
    [Abstract] [Full Text] [Related]

  • 18. miR-140-5p could suppress tumor proliferation and progression by targeting TGFBRI/SMAD2/3 and IGF-1R/AKT signaling pathways in Wilms' tumor.
    Liu Z, He F, OuYang S, Li Y, Ma F, Chang H, Cao D, Wu J.
    BMC Cancer; 2019 Apr 29; 19(1):405. PubMed ID: 31035970
    [Abstract] [Full Text] [Related]

  • 19. microRNA-383 suppresses the PI3K-AKT-MTOR signaling pathway to inhibit development of cervical cancer via down-regulating PARP2.
    Teng P, Jiao Y, Hao M, Tang X.
    J Cell Biochem; 2018 Jul 29; 119(7):5243-5252. PubMed ID: 29236322
    [Abstract] [Full Text] [Related]

  • 20. MiR-30a-5p confers cisplatin resistance by regulating IGF1R expression in melanoma cells.
    Li Y, Zhang J, Liu Y, Zhang B, Zhong F, Wang S, Fang Z.
    BMC Cancer; 2018 Apr 11; 18(1):404. PubMed ID: 29642855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.